SOPHiA GENETICS SA Ordinary Shares (SOPH) is a publicly traded Healthcare sector company. As of May 21, 2026, SOPH trades at $4.77 with a market cap of $336.70M and a P/E ratio of 0.00. SOPH moved +3.42% today. Year to date, SOPH is +5.87%; over the trailing twelve months it is +69.10%. Its 52-week range spans $2.58 to $5.70. Analyst consensus is strong buy with an average price target of $7.50. Rallies surfaces SOPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes SOPH SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $4.77 |
| Market Cap | $336.70M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.70 |
| 52-Week Low | $2.58 |
| Volume | 56.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover SOPH: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $7.50.